Wysocki, P.J.; Łobacz, M.; Potocki, P.; Kwinta, Ł.; Michałowska-Kaczmarczyk, A.; Słowik, A.; Konopka, K.; Buda-Nowak, A.
Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer. Cancers 2023, 15, 1067.
https://doi.org/10.3390/cancers15041067
AMA Style
Wysocki PJ, Łobacz M, Potocki P, Kwinta Ł, Michałowska-Kaczmarczyk A, Słowik A, Konopka K, Buda-Nowak A.
Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer. Cancers. 2023; 15(4):1067.
https://doi.org/10.3390/cancers15041067
Chicago/Turabian Style
Wysocki, Piotr J., Mateusz Łobacz, Paweł Potocki, Łukasz Kwinta, Anna Michałowska-Kaczmarczyk, Agnieszka Słowik, Kamil Konopka, and Anna Buda-Nowak.
2023. "Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer" Cancers 15, no. 4: 1067.
https://doi.org/10.3390/cancers15041067
APA Style
Wysocki, P. J., Łobacz, M., Potocki, P., Kwinta, Ł., Michałowska-Kaczmarczyk, A., Słowik, A., Konopka, K., & Buda-Nowak, A.
(2023). Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer. Cancers, 15(4), 1067.
https://doi.org/10.3390/cancers15041067
